Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.
You'll also like these stocks for their track record of earnings growth.
Teva Pharmaceutical Industries TEVA reported third-quarter 2024 adjusted earnings of 69 cents per share, which beat the Zacks Consensus Estimate of 65 cents. Adjusted earnings rose 15% year over year.Revenues...
Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.
AI could soon transform the medical technology industry, and this market leader may continue to dominate.
These healthcare stocks have fantastic dividend track records.
AbbVie ABBV is set to report third-quarter earnings on Oct. 30, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $14.28 billion and $2.93 per share, respectively.The...
In 1980, around five dozen publicly traded companies held the highest possible credit rating (AAA) from Standard & Poor's. Today, there are only two left.
These three Vanguard ETFs are worth considering for the long term.
Fewer contenders means fewer constraints on expanding market share.